CONCLUSION: There is no conclusive evidence that antipsychotic medication that raises prolactin levels increases the risk of breast cancer. Nevertheless, clinicians should always be cautious about prescribing antipsychotics for breast cancer patients. In our view, clinicians should always treat breast cancer risk factors as efficiently as possible, particularly when attending to patients who have schizophrenia.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Relationship between Prolactin, Breast cancer risk, and Antipsychotics in patients with Schizophrenia | 6 | 1346 | January 2, 2018 | |
Antipsychotics and the risk of breast cancer in women with schizophrenia | 0 | 237 | November 5, 2021 | |
Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland | 1 | 237 | August 31, 2021 | |
'Prolactin-increasing' antipsychotics tied to breast cancer in female schizophrenics | 0 | 211 | October 15, 2021 | |
Long Term Antipsychotic Use May Be Linked to Increased Breast Cancer Risk in Women With Schizophrenia | 0 | 34 | July 20, 2025 |